Korean Market
EXCH
JW Pharmaceutical
★

JW Pharmaceutical continues governance improvement: Enhanced shareholder communication and 25% dividend payout target, but still lacks CEO succession and risk management policies

 
PERI
JW Pharmaceutical
★★

JW Pharm. Q1 2026 Earnings Beat and New GLP-1 License-In Deal

 
EXCH
JW Pharmaceutical
★★★★

JW Holdings Reports Q1 2026 Operating Profit Surge 98.2% YoY, Sales Up 8.1%

 
EXCH
JW Pharmaceutical
★★

2025 Preliminary Earnings: Revenue and Operating Profit Up, Net Income Down Due to Additional Tax

 
EXCH
JW Pharmaceutical
★★★

Trading Halt for JW Joongwae Pharmaceutical due to Business Suspension

 
MATR
JW Pharmaceutical
★★

JW Pharma Faces Business Suspension for Sales Regulation Violation (Fine of 285.3 Million Won)